Publications

Dalcetrapib Reduces Risk of New-Onset Diabetes in Patients With Coronary Heart Disease

Schwartz G., Leiter L., Ballantyne C., et al.
American Diabetes Association: Diabetes Care
May 2020

VIEW PUBLICATION 

Dalcetrapib Reduces Risk of New-Onset Diabetes in Patients With Coronary Heart Disease

Schwartz G., Leiter L., Ballantyne C, et al.
Diabetes Care
March 2020

VIEW PUBLICATION ›

Clinical Pharmacokinetics and Pharmacodynamics of Dalcetrapib

Black, D.M., Bentley, D., Chapel, S., et al.
Clinical Pharmacokinetics
November 2018

VIEW PUBLICATION ›

Genotype-Dependent Effects of Dalcetrapib on Cholesterol Efflux and Inflammation: Concordance With Clinical Outcomes

Tardif J.C., Rhainds D., Brodeur M., et al.
Circulation: Cardiovascular Genetics
August 2016

VIEW PUBLICATION ›

Pharmacogenomic Determinants of the Cardiovascular Effects of Dalcetrapib.Circulation Cardiovascular Genetics

Tardif  J.C., Rheaume E., Lemieux Perreault L-P., et. al.
Circulation: Cardiovascular Genetics
January 2015

VIEW PUBLICATION ›